Small bowel imaging in inflammatory bowel disease: updates for 2023

References

• Kucharzik T, Tielbeek J, Carter D, et al. ECCO-ESGAR topical review on optimizing reporting for cross-sectional imaging in inflammatory bowel disease. J Crohns Colitis. 2022;16:523–543. doi: 10.1093/ecco-jcc/jjab180
   PubMed Web of Science ®Google Scholar
• Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting therapeutic targets in inflammatory bowel disease [STRIDE] initiative of the international organization for the study of IBD [IOIBD]: determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. doi: 10.1053/j.gastro.2020.12.031
   PubMed Web of Science ®Google Scholar
• Wilkens R, Novak KL, Maaser C, et al. Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives. Ther Adv Gastroenterol. 2021;14:17562848211006672. doi: 10.1177/17562848211006672
   Web of Science ®Google Scholar
• Grand DJ, Deepak P, Rimola J. MRE evaluation of intestinal inflammation: qualitative and quantitative assessment. Top Magn Reson Imaging. 2021;30(1):13–22. doi: 10.1097/RMR.0000000000000270
   PubMedGoogle Scholar
• Rimola J, Torres J, Kumar S, et al. Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease. Gut. 2022;71:2587–2597. doi: 10.1136/gutjnl-2021-326562
   PubMed Web of Science ®Google Scholar
• Geyl S, Guillo L, Laurent V, et al. Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review. Lancet Gastroenterol Hepatol. Lancet Gastroenterol Hepatol. 2021;6(8):659–667. doi: 10.1016/S2468-1253[21]00096-0
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Wilkens R, D’Agostino M-A, et al. Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease. Clin Gastroenterol Hepatol. 2023;21(1):153–163.e12. doi: 10.1016/j.cgh.2022.05.055
   PubMed Web of Science ®Google Scholar
• Messadeg L, Hordonneau C, Bouguen G, et al. Early transmural response assessed using Magnetic resonance imaging could predict sustained clinical remission and prevent bowel damage in patients with Crohn’s disease treated with anti-tumour necrosis factor therapy. J Crohns Colitis. 2020;14:1524–1534. doi: 10.1093/ecco-jcc/jjaa098
   PubMed Web of Science ®Google Scholar
• Weinstein-Nakar I, Focht G, Church P, et al. Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn’s disease. Clin Gastroenterol Hepatol. 2018;16(7):1089–1097.e4. doi: 10.1016/j.cgh.2018.01.024
   PubMed Web of Science ®Google Scholar
• Ma L, Li W, Zhuang N, et al. Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn’s disease. Ther Adv Gastroenterol. 2021;14:175628482110162. doi: 10.1177/17562848211016259
   Web of Science ®Google Scholar
• Goodsall TM, Noy R, Nguyen TM, et al. Systematic review: patient perceptions of monitoring tools in inflammatory bowel disease. J Can Assoc Gastroenterol. 2021;4:e31–e41. doi: 10.1093/jcag/gwaa001
   PubMedGoogle Scholar
• Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:1425–1433. doi: 10.1097/MIB.0000000000001140
   PubMed Web of Science ®Google Scholar
• METRIC investigators, Miles A, Bhatnagar G, et al. Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn’s disease: patient acceptability and perceived burden. Eur Radiol. 2019;29(3):1083–1093.
   PubMed Web of Science ®Google Scholar
• Bruining DH, Zimmermann EM, Loftus EV, et al. Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and Magnetic resonance enterography in patients with small bowel Crohn’s disease. Radiology. 2018;286:776–799. doi: 10.1148/radiol.2018171737
   PubMed Web of Science ®Google Scholar
• Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68:1115–1126. doi: 10.1136/gutjnl-2018-318081
   PubMed Web of Science ®Google Scholar
• Semelka RC, Ramalho M. Gadolinium deposition disease: Current state of knowledge and expert opinion. 2023. [cited 2023 Apr 16]. InternetPublish Ahead of Print Invest Radiol. 58(8):523–529. doi: 10.1097/RLI.0000000000000977
   PubMed Web of Science ®Google Scholar
• Puylaert CAJ, Nolthenius CJT, Tielbeek JAW, et al. Comparison of MRI activity scoring systems and features for the terminal ileum in patients with Crohn disease. Am J Roentgenol. 2019;212:W25–W31. doi: 10.2214/AJR.18.19876
   PubMed Web of Science ®Google Scholar
• Seo N, Park SH, Kim K-J, et al. MR Enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology. 2016;278:762–772. doi: 10.1148/radiol.2015150809
   PubMed Web of Science ®Google Scholar
• Taylor SA, Mallett S, Bhatnagar G, et al. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn’s disease patients: the METRIC diagnostic accuracy study. Health Technol Assess. 2019;23(66):1–270. doi: 10.3310/hta23420
   Google Scholar
• Jesuratnam-Nielsen K, Løgager VB, Munkholm P, et al. Diagnostic accuracy of three different MRI protocols in patients with inflammatory bowel disease. Acta Radiol Open. 2015;4(6):205846011558809. doi: 10.1177/2058460115588099
   Google Scholar
• Bhatnagar G, Mallett S, Quinn L, et al. Influence of oral contrast type and volume on patient experience and quality of luminal distension at MR Enterography in Crohn’s disease: an observational study of patients recruited to the METRIC trial. Eur Radiol. 2022;32:5075–5085. doi: 10.1007/s00330-022-08614-9
   PubMed Web of Science ®Google Scholar
• Parente F. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut. 2004;53:1652–1657. doi: 10.1136/gut.2004.041038
   PubMed Web of Science ®Google Scholar
• Pallotta N, Vincoli G, Montesani C, et al. Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohnʼs disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis. 2012;18(1):74–84. doi: 10.1002/ibd.21678
   PubMed Web of Science ®Google Scholar
• Taylor SA, Mallett S, Bhatnagar G, et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease [METRIC]: a multicentre trial. Lancet Gastroenterol Hepatol. 2018;3(8):548–558. doi: 10.1016/S2468-1253[18]30161-4
   PubMed Web of Science ®Google Scholar
• Goodsall TM, Nguyen TM, Parker CE, et al. Systematic review: gastrointestinal ultrasound scoring indices for inflammatory bowel disease. J Crohns Colitis. 2021;15:125–142. doi: 10.1093/ecco-jcc/jjaa129
   PubMed Web of Science ®Google Scholar
• Rao N, Kumar S, Taylor S, et al. Diagnostic pathways in Crohn’s disease. Clin Radiol. 2019;74:578–591. doi: 10.1016/j.crad.2019.03.013
   PubMed Web of Science ®Google Scholar
• Goodsall TM, Jairath V, Feagan BG, et al. Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Aliment Pharmacol Ther. 2021;53:873–886. doi: 10.1111/apt.16288
   PubMed Web of Science ®Google Scholar
• Ilvemark JFKF, Hansen T, Goodsall TM, et al. Defining Transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement. J Crohns Colitis. 2022;16(4):554–580. doi: 10.1093/ecco-jcc/jjab173
   PubMed Web of Science ®Google Scholar
• Bots S, Nylund K, Löwenberg M, et al. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores. J Crohns Colitis. 2018;12:920–929. doi: 10.1093/ecco-jcc/jjy048
   PubMed Web of Science ®Google Scholar
• Sagami S, Kobayashi T, Miyatani Y, et al. Accuracy of ultrasound for evaluation of colorectal segments in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(5):908–921.e6. doi: 10.1016/j.cgh.2020.07.067
   PubMed Web of Science ®Google Scholar
• Hanžel J, Jairath V, Ma C, et al. Responsiveness of Magnetic resonance enterography indices for evaluation of luminal disease activity in Crohn’s disease. Clin Gastroenterol Hepatol. 2022;20(11):2598–2606. doi: 10.1016/j.cgh.2022.01.055
   PubMed Web of Science ®Google Scholar
• Schulberg JD, Wright EK, Holt BA, et al. Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn’s disease strictures [STRIDENT]: an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(4):318–331. doi: 10.1016/S2468-1253[21]00393-9
   PubMed Web of Science ®Google Scholar
• Gower-Rousseau C, Sarter H, Savoye G, et al. Validation of the inflammatory bowel disease Disability index in a population-based cohort. Gut. 2017;66:588–596. doi: 10.1136/gutjnl-2015-310151
   PubMed Web of Science ®Google Scholar
• Rimola J, Alvarez-Cofiño A, Pérez-Jeldres T, et al. Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease. J Gastroenterol. 2017;52:585–593. doi: 10.1007/s00535-016-1253-6
   PubMed Web of Science ®Google Scholar
• Ordás I, Rimola J, Alfaro I, et al. Development and validation of a simplified Magnetic resonance index of activity for Crohn’s disease. Gastroenterology. 2019;157(2):432–439.e1. doi: 10.1053/j.gastro.2019.03.051
   PubMed Web of Science ®Google Scholar
• Roseira J, Ventosa AR, Sousa HT, et al. The new simplified MARIA score applies beyond clinical trials: a suitable clinical practice tool for Crohn’s disease that parallels a simple endoscopic index and fecal calprotectin. United Eur Gastroenterol J. 2020;8:1208–1216. doi: 10.1177/2050640620943089
   PubMed Web of Science ®Google Scholar
• Capozzi N, Ordás I, Fernandez-Clotet A, et al. Validation of the simplified Magnetic resonance index of activity [sMARIA] without gadolinium-enhanced sequences for Crohn’s disease. J Crohns Colitis. 2020;14:1074–1081. doi: 10.1093/ecco-jcc/jjaa030
   PubMed Web of Science ®Google Scholar
• Tao Y, Li H, Xu H, et al. Can the simplified magnetic resonance index of activity be used to evaluate the degree of activity in Crohn’s disease? BMC Gastroenterol. 2021;21:409. doi: 10.1186/s12876-021-01987-z
   PubMed Web of Science ®Google Scholar
• Bae H, Seo N, Kang EA, et al. Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn’s disease. Eur Radiol. Internet. [cited 2023 Apr 16] 2023;33(5):3266–3275. doi: 10.1007/s00330-023-09501-7
   PubMedGoogle Scholar
• Steward MJ, Punwani S, Proctor I, et al. Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol. 2012;81:2080–2088. doi: 10.1016/j.ejrad.2011.07.013
   PubMed Web of Science ®Google Scholar
• Novak KL, Kaplan GG, Panaccione R, et al. A simple ultrasound score for the accurate detection of inflammatory activity in Crohnʼs disease: Inflamm Bowel Dis. Inflamm Bowel Dis. 2017;23(11):2001–2010. doi: 10.1097/MIB.0000000000001174
   PubMed Web of Science ®Google Scholar
• Sævik F, Eriksen R, Eide GE, et al. Development and validation of a simple ultrasound activity score for Crohn’s disease. J Crohns Colitis. 2021;15:115–124. doi: 10.1093/ecco-jcc/jjaa112
   PubMed Web of Science ®Google Scholar
• Allocca M, Craviotto V, Dell’avalle C, et al. Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2022;55:446–454. doi: 10.1111/apt.16700
   PubMed Web of Science ®Google Scholar
• Novak KL, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and Development of the International bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s disease. J Crohns Colitis. 2021;15:609–616. doi: 10.1093/ecco-jcc/jjaa216
   PubMed Web of Science ®Google Scholar
• Wang L, Xu C, Zhang Y, et al. External validation and comparison of simple ultrasound activity score and international bowel ultrasound segmental activity score for Crohn’s disease. Scand J Gastroenterol. 2023;8:883–889.
   Google Scholar
• Zorzi F, Ghosh S, Chiaramonte C, et al. Response assessed by Ultrasonography as target of biological treatment for Crohn’s disease. Clin Gastroenterol Hepatol. 2020;18:2030–2037. doi: 10.1016/j.cgh.2019.10.042
   PubMed Web of Science ®Google Scholar
• Lafeuille P, Hordonneau C, Vignette J, et al. Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease. Aliment Pharmacol Ther Cited: in: PMID: 33368525. 2021;53:577–586. doi: 10.1111/apt.16232
   PubMed Web of Science ®Google Scholar
• Fernandes SR, Serrazina J, Botto IA, et al. Transmural remission improves clinical outcomes up to 5 years in Crohn’s disease. United Eur Gastroenterol J. 2023;11(1):51–59. doi: 10.1002/ueg2.12356
   PubMed Web of Science ®Google Scholar
• Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography tight control and monitoring in Crohn’s disease during different biological therapies: a multicenter study. Clin Gastroenterol Hepatol. 2022;20:e711–e722. doi: 10.1016/j.cgh.2021.03.030
   PubMed Web of Science ®Google Scholar
• Danese S, Sandborn WJ, Colombel J-F, et al. Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease. Gastroenterology. 2019;157(4):1007–1018.e7. doi: 10.1053/j.gastro.2019.06.038
   PubMed Web of Science ®Google Scholar
• Castiglione F, Mainenti P, Testa A, et al. Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with anti-TNF alpha agents. Dig Liver Dis. 2017;49:484–489. doi: 10.1016/j.dld.2017.02.014
   PubMedGoogle Scholar
• Serban ED. Treat-to-target in Crohn’s disease: will transmural healing become a therapeutic endpoint? World J Clin Cases. 2018;6:501–513. doi: 10.12998/wjcc.v6.i12.501
   PubMed Web of Science ®Google Scholar
• Fernandes SR, Rodrigues RV, Bernardo S, et al. Transmural healing is associated with improved long-term outcomes of patients with Crohnʼs disease: Inflamm Bowel Dis. Inflamm Bowel Dis. 2017;23(8):1403–1409. doi: 10.1097/MIB.0000000000001143
   PubMed Web of Science ®Google Scholar
• Zorzi F, Rubin DT, Cleveland NK, et al. Ultrasonographic transmural healing in Crohn’s disease. Am J Gastroenterol. InternetPublish Ahead of Print. [cited 2023 Apr 11] 2023;118(6):961–969. doi: 10.14309/ajg.0000000000002265
   PubMed Web of Science ®Google Scholar
• de Voogd F, Bots S, Gecse K, et al. Intestinal ultrasound early on in treatment follow-up Predicts endoscopic response to anti-TNFα treatment in Crohn’s disease. J Crohns Colitis. 2022;16(10):1598–1608. doi: 10.1093/ecco-jcc/jjac072
   PubMed Web of Science ®Google Scholar
• Pariente B, Mary J-Y, Danese S, et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. 2015;148:52–63.e3. doi: 10.1053/j.gastro.2014.09.015
   PubMed Web of Science ®Google Scholar
• Pariente B, Torres J, Burisch J, et al. Validation and update of the Lémann index to measure cumulative structural bowel damage in Crohn’s disease. Gastroenterology. 2021;161(3):853–864.e13. doi: 10.1053/j.gastro.2021.05.049
   PubMed Web of Science ®Google Scholar
• Kumar S, Plumb A, Mallett S, et al. METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study. BMJ Open. 2022;12:e067265. doi: 10.1136/bmjopen-2022-067265
   PubMedGoogle Scholar
• Radford SJ, Taylor S, Moran G. Ultrasound use to assess Crohn’s disease in the UK: a survey of British Society of Gastroenterology Inflammatory Bowel Disease Group members. Frontline Gastroenterol. 2022;13:471–476. doi: 10.1136/flgastro-2021-102065
   PubMed Web of Science ®Google Scholar
• Allocca M, Fiorino G, Bonifacio C, et al. Comparative accuracy of bowel ultrasound versus Magnetic resonance enterography in combination with colonoscopy in assessing Crohn’s disease and guiding clinical decision-making. J Crohns Colitis. 2018;12:1280–1287. doi: 10.1093/ecco-jcc/jjy093
   PubMed Web of Science ®Google Scholar
• Calabrese E, Maaser C, Zorzi F, et al. Bowel ultrasonography in the management of Crohnʼs disease. A review with recommendations of an International panel of experts: Inflamm bowel Dis. Inflamm Bowel Dis. 2016;22(5):1168–1183. doi: 10.1097/MIB.0000000000000706
   PubMed Web of Science ®Google Scholar
• Servais L, Boschetti G, Meunier C, et al. Intestinal conventional ultrasonography, Contrast-Enhanced ultrasonography and Magnetic resonance enterography in assessment of Crohn’s disease activity: a comparison with surgical histopathology analysis. Dig Dis Sci. 2022;67:2492–2502. doi: 10.1007/s10620-021-07074-3
   PubMed Web of Science ®Google Scholar
• Kopylov U, Yung DE, Engel T, et al. Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn’s disease: systematic review and meta-analysis. Dig Liver Dis. 2017;49:854–863. doi: 10.1016/j.dld.2017.04.013
   PubMedGoogle Scholar
• Xu C, Li L, Zhang Y, et al. Diagnostic accuracy of different cross-sectional imaging techniques for disease location and activity in Crohn’s disease and external validation and comparison of MARIAs and IBUS-SAS. Abdom Radiol. Internet. [cited 2023 Apr 17]. 2022. doi: 10.1007/s00261-022-03751-7
   Web of Science ®Google Scholar
• García-Bosch O, Ordás I, Aceituno M, et al. Comparison of diagnostic accuracy and impact of Magnetic resonance imaging and colonoscopy for the management of Crohn’s disease. J Crohns Colitis. 2016;10:663–669. doi: 10.1093/ecco-jcc/jjw015
   PubMed Web of Science ®Google Scholar
• Rieder F, Latella G, Magro F, et al. European Crohn’s and Colitis Organisation Topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10:873–885. doi: 10.1093/ecco-jcc/jjw055
   PubMed Web of Science ®Google Scholar
• Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease. Aliment Pharmacol Ther. 2018;48(3):347–357. doi: 10.1111/apt.14853
   PubMed Web of Science ®Google Scholar
• Li X, Mao R, Huang S, et al. Characterization of degree of intestinal fibrosis in patients with Crohn disease by using magnetization transfer MR Imaging. Radiology. 2018;287:494–503. doi: 10.1148/radiol.2017171221
   PubMed Web of Science ®Google Scholar
• Coimbra A, Rimola J, Cuatrecasas M, et al. Magnetic resonance enterography and histology in patients with fibrostenotic Crohn’s disease: a multicenter study. Clin Transl Gastroenterol. 2022;13:e00505. doi: 10.14309/ctg.0000000000000505
   PubMed Web of Science ®Google Scholar
• Caron B, Laurent V, Odille F, et al. New magnetic resonance imaging sequences for fibrosis assessment in Crohn’s disease: a pilot study. Scand J Gastroenterol. 2022;57:1450–1453. doi: 10.1080/00365521.2022.2094727
   PubMed Web of Science ®Google Scholar
• Dal Buono A, Faita F, Peyrin-Biroulet L, et al. Ultrasound elastography in inflammatory bowel diseases: a systematic review of accuracy compared with histopathological assessment. J Crohns Colitis. 2022;16:1637–1646. doi: 10.1093/ecco-jcc/jjac082
   PubMed Web of Science ®Google Scholar
• Orlando S, Fraquelli M, Coletta M, et al. Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn’s disease treated with anti-tumour necrosis factor antibodies. J Crohns Colitis. 2018;12:63–70. doi: 10.1093/ecco-jcc/jjx116
   PubMed Web of Science ®Google Scholar
• Avila F, Caron B, Hossu G, et al. Magnetic resonance elastography for assessing fibrosis in patients with Crohn’s disease: a Pilot study. Dig Dis Sci. 2022;67:4518–4524. doi: 10.1007/s10620-021-07311-9
   PubMed Web of Science ®Google Scholar
• Scharitzer M, Macher-Beer A, Mang T, et al. Evaluation of intestinal fibrosis with 68 Ga-FAPI PET/MR enterography in Crohn disease. Radiology. 2023;307(3):222389. doi: 10.1148/radiol.222389
   Google Scholar
• QK-T N, Triumbari EKA, Omidvari N, et al. Total-body PET/CT – first clinical experiences and future perspectives. Semin Nucl Med. Cited: in: PMID: 35272853. 2022;52(3):330–339. doi: 10.1053/j.semnuclmed.2022.01.002
   PubMed Web of Science ®Google Scholar
• Huh JY, Park YJ, Ham M, et al. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37:365–371. doi: 10.14348/molcells.2014.0074
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander? Gut. 2007;56:577–583. doi: 10.1136/gut.2005.082925
   PubMed Web of Science ®Google Scholar
• Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation – Visceral obesity and creeping fat. Front Immunol. Internet. 2014. [cited 2023 Apr 14];5 . doi: 10.3389/fimmu.2014.00462
   PubMed Web of Science ®Google Scholar
• Coffey CJ, Kiernan MG, Sahebally SM, et al. Inclusion of the mesentery in ileocolic resection for Crohn’s disease is associated with reduced surgical recurrence. J Crohns Colitis. 2018;12:1139–1150. doi: 10.1093/ecco-jcc/jjx187
   PubMedGoogle Scholar
• CWY H, Martin A, Sepich-Poore GD, et al. Translocation of viable Gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell. 2020;183(3):666–683.e17. doi: 10.1016/j.cell.2020.09.009
   PubMed Web of Science ®Google Scholar
• Boronat-Toscano A, Monfort-Ferré D, Menacho M, et al. Anti-TNF therapies suppress adipose tissue inflammation in Crohn’s disease. Int J Mol Sci Cited: in: PMID: 36232469. 2022;23:11170. doi: 10.3390/ijms231911170
   PubMed Web of Science ®Google Scholar
• Li X-H, Feng S-T, Cao Q-H, et al. Degree of creeping fat assessed by computed tomography enterography is associated with intestinal fibrotic stricture in patients with Crohn’s disease: a potentially novel mesenteric creeping fat index. J Crohns Colitis. 2021;15:1161–1173. doi: 10.1093/ecco-jcc/jjab005
   PubMed Web of Science ®Google Scholar
• Zhou Z, Xiong Z, Shen Y, et al. Magnetic resonance imaging-based body composition is associated with nutritional and inflammatory status: a longitudinal study in patients with Crohn’s disease. Insights Imaging. 2021;12:178. doi: 10.1186/s13244-021-01121-3
   PubMed Web of Science ®Google Scholar
• Ando K, Uehara K, Sugiyama Y, et al. Correlation among body composition parameters and long-term outcomes in Crohn’s disease after anti-TNF therapy. Front Nutr Cited: in: PMID: 35433773. 2022;9:765209. doi: 10.3389/fnut.2022.765209
   PubMed Web of Science ®Google Scholar
• Odille F, Menys A, Ahmed A, et al. Quantitative assessment of small bowel motility by nonrigid registration of dynamic MR images. Magn Reson Med. 2012;68:783–793. doi: 10.1002/mrm.23298
   PubMed Web of Science ®Google Scholar
• Menys A, Puylaert C, Tutein Nolthenius CE, et al. Quantified terminal ileal motility during MR Enterography as a biomarker of Crohn disease activity: prospective multi-institution study. Radiology. 2018;289:428–435. doi: 10.1148/radiol.2018180100
   PubMed Web of Science ®Google Scholar
• de Jonge CS, Smout AJPM, Nederveen AJ, et al. Evaluation of gastrointestinal motility with MRI: advances, challenges and opportunities. Neurogastroenterol Motil. 2018;30(1):e13257. doi: 10.1111/nmo.13257
   Web of Science ®Google Scholar
• Plumb AA, Menys A, Russo E, et al. Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther. 2015;42:343–355. doi: 10.1111/apt.13275
   PubMed Web of Science ®Google Scholar
• Gollifer RM, Menys A, Plumb A, et al. Automated versus subjective assessment of spatial and temporal MRI small bowel motility in Crohn’s disease. Clin Radiol. 2019;74:.e814.9–.e814.19. doi: 10.1016/j.crad.2019.06.016
   Web of Science ®Google Scholar
• Dohan A, Taylor S, Hoeffel C, et al. Diffusion-weighted MRI in Crohn’s disease: Current status and recommendations. J Magn Reson Imaging. 2016;44:1381–1396. doi: 10.1002/jmri.25325
   PubMed Web of Science ®Google Scholar
• Thormann M, Melekh B, Bär C, et al. Apparent diffusion coefficient for assessing Crohn’s disease activity: a meta-analysis. Eur Radiol. 2023;33(3):1677–1686. doi: 10.1007/s00330-022-09149-9
   PubMed Web of Science ®Google Scholar
• Tielbeek JAW, Ziech MLW, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24:619–629. doi: 10.1007/s00330-013-3015-7
   PubMed Web of Science ®Google Scholar
• Ripollés T, Martínez-Pérez MJ, Paredes JM, et al. The role of intravenous contrast agent in the sonographic assessment of Crohn’s disease activity: is contrast agent injection necessary? J Crohns Colitis. 2019;13:585–592. doi: 10.1093/ecco-jcc/jjy204
   PubMed Web of Science ®Google Scholar
• Fulwadhva UP, Wortman JR, Sodickson AD. Use of Dual-energy CT and iodine maps in evaluation of bowel disease. Radiographics. 2016;36:393–406. doi: 10.1148/rg.2016150151
   PubMed Web of Science ®Google Scholar
• Dua A, Sharma V, Gupta P. Dual energy computed tomography in Crohn’s disease: a targeted review. Expert Rev Gastroenterol Hepatol. 2022;16:699–705. doi: 10.1080/17474124.2022.2105203
   PubMed Web of Science ®Google Scholar
• Zhu C, Hu J, Rong C, et al. Mucosal healing assessment in Crohn’s disease with normalized iodine concentration from dual-energy CT enterography: comparison with endoscopy. Insights Imaging. 2023;14:63. doi: 10.1186/s13244-023-01397-7
   PubMed Web of Science ®Google Scholar
• Stidham RW, Enchakalody B, Waljee AK, et al. Assessing small bowel stricturing and morphology in Crohn’s disease using semi-automated image analysis. Inflamm Bowel Dis. 2020;26:734–742. doi: 10.1093/ibd/izz196
   PubMed Web of Science ®Google Scholar
• Puylaert CAJ, Schüffler PJ, Naziroglu RE, et al. Semiautomatic assessment of the terminal ileum and colon in patients with Crohn disease using MRI [the VIGOR++ project]. Acad Radiol. 2018;25(8):1038–1045. doi: 10.1016/j.acra.2017.12.024
   PubMed Web of Science ®Google Scholar
• De Kock I, Bos S, Delrue L, et al. MRI texture analysis of T2-weighted images is preferred over magnetization transfer imaging for readily longitudinal quantification of gut fibrosis. Eur Radiol. Internet. [cited 2023 Apr 23] 2023;33(9):5943–5952. doi: 10.1007/s00330-023-09624-x
   PubMed Web of Science ®Google Scholar
• Meng J, Luo Z, Chen Z, et al. Intestinal fibrosis classification in patients with Crohn’s disease using CT enterography–based deep learning: comparisons with radiomics and radiologists. Eur Radiol. 2022;32:8692–8705. doi: 10.1007/s00330-022-08842-z
   PubMed Web of Science ®Google Scholar
• Jauregui-Amezaga A, Rimola J, Ordás I, et al. Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn’s disease in the era of biologics. Gut. 2015;64:1397–1402. doi: 10.1136/gutjnl-2014-308101
   PubMed Web of Science ®Google Scholar
• Castiglione F, Imperatore N, Testa A, et al. One-year clinical outcomes with biologics in Crohn’s disease: transmural healing compared with mucosal or no healing. Aliment Pharmacol Ther. 2019;49:1026–1039. doi: 10.1111/apt.15190
   PubMed Web of Science ®Google Scholar
• Fernández-Clotet A, Panés J, Ricart E, et al. Predictors of bowel damage in the long-term progression of Crohn’s disease. World J Clin Cases. 2022;10:12208–12220. doi: 10.12998/wjcc.v10.i33.12208
   PubMed Web of Science ®Google Scholar
• Fiorino G, Morin M, Bonovas S, et al. Prevalence of bowel damage assessed by cross-sectional imaging in early Crohn’s disease and its impact on disease outcome. J Crohns Colitis. 2016;jjwR̥185. doi: 10.1093/ecco-jcc/jjw185
   Web of Science ®Google Scholar
• Dane B, Qian K, Krieger R, et al. Correlation between imaging findings on outpatient MR enterography (MRE) in adult patients with Crohn disease and progression to surgery within 5 years. Abdom Radiol. 2022;47(10):3424–3435. doi: 10.1007/s00261-022-03624-z
   PubMed Web of Science ®Google Scholar
• Bachour SP, Shah RS, Lyu R, et al. Test characteristics of cross-sectional imaging and concordance with endoscopy in postoperative Crohn’s disease. Clin Gastroenterol Hepatol. 2022;20(10):2327–2336.e4. doi: 10.1016/j.cgh.2021.12.033
   PubMed Web of Science ®Google Scholar
• Le Berre C, Peyrin-Biroulet L, Sandborn WJ, et al. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology. 2021;160(5):1452–1460.e21. doi: 10.1053/j.gastro.2020.10.065
   PubMed Web of Science ®Google Scholar